Keynote-022 : pembrolizumab with trametinib in patients with BRAF wild-type melanoma or advanced solid tumours irrespective of BRAF mutation

Michele Maio, Matteo S. Carlino, Anthony M. Joshua, Elaine McWhirter, Antoni Ribas, Paolo A. Ascierto, Wilson H. Miller, Marcus O. Butler, Pier Francesco Ferrucci, Robert R. Zielinski, Michele Del Vecchio, Eduard Gasal, Razi Ghori, Scott J. Diede, Elizabeth Croydon, Omid Hamid

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Keynote-022 : pembrolizumab with trametinib in patients with BRAF wild-type melanoma or advanced solid tumours irrespective of BRAF mutation'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry